Blockage of the afferent sensitive pathway prevents sympathetic atrophy and hemodynamic alterations in rat portal hypertension

Liver International

Volumn 32, Issue 8, 2012, Pages 1295-1305

  Ezkurdia, Nahia ^a   Coll, Mar ^a   Raurell, Imma ^a   Rodriguez, Sarai ^a   Cuenca, Silvia ^a   González, Antonio ^a   Guardia, Jaime ^a,b   Esteban, Rafael ^a,b   Genescà, Joan ^a,b   Martell, María ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Afferent sensitive signal; Capsaicin; Cirrhosis; Portal hypertension; Sympathetic atrophy

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; NERVE GROWTH FACTOR; NEURONAL NITRIC OXIDE SYNTHASE; NEUROTROPHIN RECEPTOR P75; PRO NERVE GROWTH FACTOR; PROTEIN C FOS; PROTEIN PRECURSOR; SEMAPHORIN 3A; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; VESICULAR ACETYLCHOLINE TRANSPORTER;

ADRENERGIC NERVE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MALE; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD FLOW; NERVE FIBER; NEWBORN; NITRERGIC NERVE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; PREGANGLIONIC NERVE CELL; PROTEIN EXPRESSION; RAT; SENSORY NERVE; SPLANCHNIC BLOOD FLOW; SUPERIOR MESENTERIC ARTERY; SUPRAOPTIC NUCLEUS; SYMPATHETIC ATROPHY; SYMPATHETIC DYSTROPHY; SYMPATHETIC GANGLION; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; VASODILATATION; VEIN LIGATION; WESTERN BLOTTING;

AFFERENT PATHWAYS; ANIMALS; ANIMALS, NEWBORN; ATROPHY; AUTONOMIC NERVOUS SYSTEM DISEASES; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; DISEASE MODELS, ANIMAL; GANGLIA, SYMPATHETIC; HEMODYNAMICS; HYPERTENSION, PORTAL; MALE; MEMBRANE PROTEINS; NITRIC OXIDE SYNTHASE TYPE I; PORTAL VEIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SENSORY SYSTEM AGENTS; SPLANCHNIC CIRCULATION; SUPRAOPTIC NUCLEUS; VASODILATION;

EID: 84865180336     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02762.x     Document Type: Article

References (34)

1. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006; 43: S121-31.
2. Martell M, Coll M, Ezkurdia N, Raurell I, Genesca J. Physiopathology of splanchnic vasodilation in portal hypertension. World J Hepatol 2010; 2: 208-20.
3. Rodriguez-Vilarrupla A, Fernandez M, Bosch J, Garcia-Pagan JC. Current concepts on the pathophysiology of portal hypertension. Ann Hepatol 2007; 6: 28-36.
4. Coll M, Genesca J, Raurell I, et al. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension. J Hepatol 2008; 49: 43-51.
5. Coll M, Martell M, Raurell I, et al. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension. Liver Int 2010; 30: 593-602.
6. Gibbins IL, Jobling P, Morris JL. Functional organization of peripheral vasomotor pathways. Acta Physiol Scand 2003; 177: 237-45.
7. Holzer P. Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol 1992; 121: 49-146.
8. Keef KD, Kreulen DL. Venous mechanoreceptor input to neurones in the inferior mesenteric ganglion of the guinea-pig. J Physiol 1986; 377: 49-59.
9. Stein RD, Genovesi S, Demarest KT, Weaver LC. Capsaicin treatment attenuates the reflex excitation of sympathetic activity caused by chemical stimulation of intestinal afferent nerves. Brain Res 1986; 397: 145-51.
10. Buck SH, Burks TF. The neuropharmacology of capsaicin: review of some recent observations. Pharmacol Rev 1986; 38: 179-226.
11. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988; 24: 739-68.
12. Maggi CA, Meli A. The sensory-efferent function of capsaicin-sensitive sensory neurons. Gen Pharmacol 1988; 19: 1-43.
13. Liu H, Schuelert N, McDougall JJ, Lee SS. Central neural activation of hyperdynamic circulation in portal hypertensive rats depends on vagal afferent nerves. Gut 2008; 57: 966-73.
14. Song D, Liu H, Sharkey KA, Lee SS. Hyperdynamic circulation in portal-hypertensive rats is dependent on central c-fos gene expression. Hepatology 2002; 35: 159-66.
15. Jancso G, Kiraly E, Jancso-Gabor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature 1977; 270: 741-3.
16. Doignon I, Julien B, Serriere-Lanneau V, et al. Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis. J Hepatol 2011; 54: 481-8.
17. Lee SS, Sharkey KA. Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats. Am J Physiol 1993; 264: G868-73.
18. Li Y, Song D, Zhang Y, Lee SS. Effect of neonatal capsaicin treatment on haemodynamics and renal function in cirrhotic rats. Gut 2003; 52: 293-9.
19. Song D, Sharkey KA, Breitman DR, Zhang Y, Lee SS. Disordered central cardiovascular regulation in portal hypertensive and cirrhotic rats. Am J Physiol Gastrointest Liver Physiol 2001; 280: G420-30.
20. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991; 43: 143-201.
21. Nagy JI, van der KD. Effects of neonatal capsaicin treatment on nociceptive thresholds in the rat. J Neurosci 1983; 3: 1145-50.
22. Bendtsen F, Schifter S, Henriksen JH. Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis. J Hepatol 1991; 12: 118-23.
23. Kawasaki H, Takasaki K, Saito A, Goto K. Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature 1988; 335: 164-7.
24. Jurzik L, Froh M, Straub RH, Scholmerich J, Wiest R. Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension. J Hepatol 2005; 43: 258-65.
25. Kwon SY, Groszmann RJ, Iwakiri Y. Increased neuronal nitric oxide synthase interaction with soluble guanylate cyclase contributes to the splanchnic arterial vasodilation in portal hypertensive rats. Hepatol Res 2007; 37: 58-67.
26. Hatanaka Y, Hobara N, Honghua J, et al. Neuronal nitric-oxide synthase inhibition facilitates adrenergic neurotransmission in rat mesenteric resistance arteries. J Pharmacol Exp Ther 2006; 316: 490-7.
27. Fernandez M, Casadevall M, Schuligoi R, et al. Neonatal capsaicin treatment does not prevent splanchnic vasodilatation in portal-hypertensive rats. Hepatology 1994; 20: 1609-14.
28. Glebova NO, Ginty DD. Growth and survival signals controlling sympathetic nervous system development. Annu Rev Neurosci 2005; 28: 191-222.
29. Roth L, Koncina E, Satkauskas S, et al. The many faces of semaphorins: from development to pathology. Cell Mol Life Sci 2009; 66: 649-66.
30. Shirvan A, Ziv I, Fleminger G, et al. Semaphorins as mediators of neuronal apoptosis. J Neurochem 1999; 73: 961-71.
31. Shirvan A, Shina R, Ziv I, Melamed E, Barzilai A. Induction of neuronal apoptosis by Semaphorin3A-derived peptide. Brain Res Mol Brain Res 2000; 83: 81-93.
32. Ben-Zvi A, Ben-Gigi L, Yagil Z, Lerman O, Behar O. Semaphorin3A regulates axon growth independently of growth cone repulsion via modulation of TrkA signaling. Cell Signal 2008; 20: 467-79.
33. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677-736.
34. Masoudi R, Ioannou MS, Coughlin MD, et al. Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors. J Biol Chem 2009; 284: 18424-33.